FdaApplication
BLA 021810
Identifiers
- fda_app_no: BLA021810
Properties
| Property | Value |
|---|---|
| applicant_name | Novo Nordisk Inc. |
| application_type | BLA |
| approval_date | 2008-08-26 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| NOVOLOG MIX 50/50 | INSULIN ASPART PROTAMINE RECOMBINANT; INSULIN ASPART RECOMBINANT | 150UNITS/3ML (50UNITS/ML); 150UNITS/3ML (50UNITS/ML) | Injectable Suspension |
| NOVOLOG MIX 50/50 | — | 150UNITS/3ML (50UNITS/ML); 150UNITS/3ML (50UNITS/ML) | Injectable Suspension |
2 products